Pharmacoepidemiologic Screening of Potential Oral Anticoagulant Drug Interactions Leading to Thromboembolic Events-Reference-Cited by-同舟云学术

Pharmacoepidemiologic Screening of Potential Oral Anticoagulant Drug Interactions Leading to Thromboembolic Events

Published:2020-05-16 Issue:2 Volume:108 Page:377-386
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Zhou Meijia¹,Leonard Charles E.¹,Brensinger Colleen M.¹,Bilker Warren B.¹,Kimmel Stephen E.¹²,Hecht Todd E. H.³,Hennessy Sean¹⁴

Affiliation:

1. Department of Biostatistics, Epidemiology, and Informatics Center for Pharmacoepidemiology Research and Training Center for Clinical Epidemiology and Biostatistics University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

2. Department of Medicine University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

3. Division of General Internal Medicine University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

4. Department of Systems Pharmacology and Translational Therapeutics University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania USA

Funder

United States Department of Health and Human Services’ National Institute on Aging

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1845

Reference49 articles.

1. Plenty of pills: polypharmacy prevails in patients of a Danish anticoagulant clinic

2. Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation

3. Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial